Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine injection in previously untreated myelodysplastic syndromes
CTR20160431Phase 4Active
- Sponsor
- Shandong New Era Pharmaceutical
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of decitabine in myelodysplastic syndrome (MDS), sponsored by Shandong New Era Pharmaceutical. Started Sep 2016; status: active.
02
Drugs
decitabine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on CTR20160431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160431.